Healthcare
Modernisation of Indian Medicines Pharmaceutical Corporation
By PIB, India
Mar 30, 2005, 18:38

The Cabinet Committee on Economic Affairs (CCEA) last evening gave its approval for the implementation of the 2nd phase of modernization by enhancing the authorized and paid up Share Capital of the Indian Medicines Pharmaceutical Corporation Ltd. (IMPCL), Uttaranchal to Rs.700 lakh and sanction for making GOI investment of Rs.500 lakh in equity of the Company.

The Company is continuously profit making. Modernisation would help in expanding the operations of the Company thereby ensuring supply of quality medicines.

The Indian Medicines Pharmaceutical Corporation Ltd., Mohan, Uttaranchal is a PSU under the M/o Health & Family Welfare, set up with the primary objective of manufacturing quality Ayurvedic and Unani drugs for dispensaries and hospitals under the CGHS and Research Councils of Indian System of Medicine. The authorized and paid-up Share Capital of the Corporation is Rs.200 lakh, out of which 51 per cent is contributed by the Central Government and 49 per cent by the Government of Uttaranchal, represented by M/s. Kumaon Mandal Vikas Nigam Ltd.

RK/HS/LV

All rights reserved by www.rxpgnews.com